Quest Diagnostics — PathAI software and algorithm licensing (2024)

Quest will license AISight and PathAI algorithms for U.S. pathology operations. The licensing agreements are separate from Quest's acquisition of selected laboratory assets.

Enterprise Healthcare & life sciences

Verified

Announced
1 May 2024 1

Read the source Compare with related

Contract facts

Source per value
DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.
2024-05-011
BuyerThe purchasing organisation or named customer.
Quest Diagnostics1
VendorThe contracting supplier or AI provider, as named in the source.
PathAI1
SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.
Enterprise
Product or programThe AI product, model, platform or program supplied.
AISight1
Contract typeThe vehicle as the source names it: IDIQ, task order, other transaction agreement, blanket purchase agreement, enterprise agreement.
Software and algorithm licensing agreements1
Delivery locationWhere the service is delivered, when the source says.
United States1

Sources

  1. pathai.com accessed 2026-11-11

Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.

Related contracts

All 87 contracts
  1. Undisclosed
  2. Eli Lilly — Isomorphic Labs AI discovery collaboration (2024)

    Eli Lilly and Company · Isomorphic Labs

    Undisclosed
  3. Undisclosed
  4. Undisclosed
  5. Undisclosed

Spot a change?

Amendment, renewal or a figure that moved? Email hello@aicontractstracker.com with the source link and we update this row and its verified date.